top of page
We work with modern, innovative biopharma companies in the earliest stages of development, including pre-IND and phase 1, to provide pharmacovigilance consultative advisory support. These agile and fast-paced companies do not need to retain full-time PV expertise. However, when key questions arise or critical investments and decisions are being made that set down foundations for further development activities, it is essential to have early guidance from pharmacovigilance experts for everything from regulatory compliance to medical safety considerations.
bottom of page